Acutus Medical, Inc. Announces Proposed Public Offering of Common Stock
July 12, 2021 16:30 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today announced it has commenced an underwritten public offering of 5,500,000...
Acutus Medical Reports Preliminary Unaudited Second Quarter 2021 Financial Results
July 12, 2021 16:01 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias...
Acutus Medical Receives FDA Approval to Initiate US Atrial Fibrillation IDE Trial with the AcQBlate® FORCE Sensing Ablation System
May 27, 2021 08:00 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., May 27, 2021 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today...
Acutus Medical to Present at the 41st Annual William Blair Growth Stock Conference
May 20, 2021 16:01 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and...
Acutus Medical Announces CE Mark Approval for Suite of Next Generation EP Products in Europe
May 12, 2021 16:05 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and...
Acutus Medical Reports First Quarter 2021 Financial Results
May 12, 2021 16:01 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias...
Acutus Medical to Announce First Quarter 2021 Financial Results
April 28, 2021 16:01 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed...
Acutus Medical to Participate in Upcoming Investor Conferences
April 20, 2021 16:01 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed...
Acutus Medical Announces FDA Clearance of AcQCross™, a Full Suite of Universal Transseptal Crossing Devices
April 13, 2021 08:00 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., April 13, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed...
Acutus Medical Initiates First IDE Therapy Trial with the AcQBlate® FORCE Sensing Ablation System
April 05, 2021 08:00 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today...